Company intelligence / Profile preview

Primo Capital

Ownership: Private
Development stage: Other

Overview

Primo Capital is the leading independent Italian alternative investment platform focused on key technological sectors including digital, space economy, climate tech, and healthcare. It operates across venture capital and private equity segments with over €500 million committed across multiple funds. In healthcare specifically, it invests through its dedicated fund "Primo Health," targeting innovative small and medium-sized companies in medical devices, pharmaceutical supply chain, private healthcare services, and veterinary medicine.

Industry: Investors

Partnerships

European Investment FundFondo Italiano d’InvestimentoFondazione ENPAM

Beyond the preview

Go deeper on Primo Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Primo Capital.

Explore the full profile